ARCT
ARCT
NASDAQ · Biotechnology

Arcturus Therapeutics Holdin

$8.31
-0.05 (-0.60%)
Day Range $8.27 — $9.78
52W Range $5.50 — $17.96
Open$9.66
Previous Close$8.36
Day High$9.78
Day Low$8.27
52W High$17.96
52W Low$5.50
Volume—
Avg Volume791.0K
Market Cap242.25M
P/E Ratio—
EPS$-3.31
SectorBiotechnology

Analyst Ratings

Strong Buy
19 analysts
16 Buy 3 Hold 0 Sell
Price Target +217.8% upside
Current
$8.31
Target
$26.41
$16.23 $26.41 avg $33.18

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 77.94M 105.94M 31.39M
Net Income -62,504,453 -76,463,242 -5,088,256
Profit Margin -80.2% -76.2% -16.2%
EBITDA -69,584,700 -89,853,833 -7,015,778
Free Cash Flow — — -5,929,972
Rev Growth -26.4% -26.4% +5.3%
Debt/Equity — — 0.28

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $294.55 -0.16% 50.3 520.47B
AMGN Amgen Inc $456.60 -1.24% 26.9 252.64B
GILD Gilead Sciences Inc $169.42 +1.10% — 208.95B
VRTX Vertex Pharmaceuticals Inc $531.97 -1.08% 33.9 134.82B
REGN Regeneron Pharmaceuticals $951.08 -0.14% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $159.73 -3.22% 7.7 20.98B

ARCT News

No news for ARCT yet

Quick Stats

Market Cap242.25M
P/E Ratio—
EPS$-3.31
Volume—
SectorBiotechnology